Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies

Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies

Background The PROTECT‐AF (Watchman Left Atrial Appendage Closure Technology for Embolic Protection in Patients With Atrial Fibrillation) and PREVAIL (Evaluation of the Watchman LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy) trials demonstrated noninferior...

Full description

Bibliographic Details
Main Authors: Tom F. Brouwer, William Whang, Kenji Kuroki, Jonathan L. Halperin, Vivek Y. Reddy
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulation
atrial fibrillation
left atrial appendage
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.013525

Similar Items

Similar Items